DE60020981D1 - Ant-1 als therapeutisches zielmolekül - Google Patents

Ant-1 als therapeutisches zielmolekül

Info

Publication number
DE60020981D1
DE60020981D1 DE60020981T DE60020981T DE60020981D1 DE 60020981 D1 DE60020981 D1 DE 60020981D1 DE 60020981 T DE60020981 T DE 60020981T DE 60020981 T DE60020981 T DE 60020981T DE 60020981 D1 DE60020981 D1 DE 60020981D1
Authority
DE
Germany
Prior art keywords
ant
target molecule
therapeutic target
dilated cardiomyopathy
mitochondria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60020981T
Other languages
English (en)
Other versions
DE60020981T2 (de
Inventor
Stefan Grimm
Manuel Bauer
Alexis Schubert
Ursula Cramer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften eV filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Application granted granted Critical
Publication of DE60020981D1 publication Critical patent/DE60020981D1/de
Publication of DE60020981T2 publication Critical patent/DE60020981T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52—Isomerases (5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60020981T 1999-09-10 2000-09-08 ANT-1 als Arzneimittelziel Expired - Fee Related DE60020981T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15304099P 1999-09-10 1999-09-10
US153040P 1999-09-10
PCT/EP2000/008812 WO2001019384A2 (de) 1999-09-10 2000-09-08 Ant-1 as drug target

Publications (2)

Publication Number Publication Date
DE60020981D1 true DE60020981D1 (de) 2005-07-28
DE60020981T2 DE60020981T2 (de) 2005-12-15

Family

ID=22545531

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60020981T Expired - Fee Related DE60020981T2 (de) 1999-09-10 2000-09-08 ANT-1 als Arzneimittelziel

Country Status (5)

Country Link
EP (1) EP1212078B1 (de)
AT (1) ATE298243T1 (de)
AU (1) AU7652000A (de)
DE (1) DE60020981T2 (de)
WO (1) WO2001019384A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017190016A1 (en) * 2016-04-29 2017-11-02 University Of South Florida Cyclophilin 40 for reduction of neurotoxic fibrils and treatment of neurodegenerative diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE375362T1 (de) * 1998-06-25 2007-10-15 Kyogo Itoh Von cyclophilin b abstammende tumorantigen- peptide
IL142895A0 (en) * 1998-11-03 2002-04-21 Mitokor Adenine nucleotide translocator polyptides

Also Published As

Publication number Publication date
EP1212078A2 (de) 2002-06-12
DE60020981T2 (de) 2005-12-15
AU7652000A (en) 2001-04-17
EP1212078B1 (de) 2005-06-22
ATE298243T1 (de) 2005-07-15
WO2001019384A3 (de) 2001-09-27
WO2001019384A2 (de) 2001-03-22

Similar Documents

Publication Publication Date Title
BRPI0517458A (pt) derivados da xantina com atividade para o receptor hm74a
LU93015I2 (fr) Carfilzomib eventuellement sous forme d'un sel pharmaceutiquement acceptable
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
BRPI0613005A8 (pt) uso de polipeptídeos de aprotinina como veículos em conjugados farmacêuticos.
BRPI0409136A (pt) composto heteroaromático pentacìclico e uso medicinal do mesmo
BRPI0615145A2 (pt) derivados de xantina como agonistas hm74a seletivos
ATE249214T1 (de) Pentafluorobenzensulfonamide und analoge
EA200000461A1 (ru) Компоненты, улучшающие кожную проницаемость
DK1162982T3 (da) Anvendelse af stabiliserede oligonucleotider til fremstilling af et lægemiddel med antitumoral virkning
BR0316234A (pt) Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos
BR0214277A (pt) Solvatos de paclitaxel
TR200102603T2 (tr) Antitümör aktiviteye sahip olan kamptotesin türevleri
BRPI0507675A (pt) derivados de 2'-c-metil nucleosìdeo
MA28038A1 (fr) Thienopyrazoles
WO2001010468A3 (en) Drug-carrier complexes and methods of use thereof
ATE311464T1 (de) Nk zellen-aktivierende rezeptoren und deren therapeutische und diagnostische verwendungen
ES2167682T3 (es) Derivados del acido neuraminico, su preparacion y su uso medico.
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
Rodgers et al. Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors
CY1106194T1 (el) Θepαπευτικη αγωγη της δυσκινησιας
ATE321782T1 (de) Membrantranslokierendes peptid als wirkstofftransportsystem
ATE509958T1 (de) Gegen cathepsin s gerichtete therapie
AR022940A1 (es) Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimiento para su preparacion
SE0004710L (sv) System och förfarande
ES2177849T3 (es) Preparado farmaceutico, que contiene 2-fenil-1,2-benzoisoselenazol-3(2h)-ona, para el tratamiento de la enfermedad de alzheimer.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee